Used primarily to treat acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Its long half-life allows for a single-dose intravenous administration, improving patient compliance and enabling treatment in outpatient settings. Due to its mechanism of action involving cell wall inhibition and disruption of membrane integrity, it shows potent bactericidal activity. It is also being explored for use in other serious infections such as bacteremia and endocarditis when caused by resistant Gram-positive organisms.